系統的な薬物投与可能な全ゲノムメンデルのランダム化により,冠動脈疾患の遺伝的に支持された治療標的が特定されました

Boteng Yan^1,2, Peijiang Pan³, Wenfu Tao⁴

¹Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.

|February 15, 2026

まとめ

この研究では,メンデルのランダム化を使用して,冠動脈疾患 (CAD) の66の遺伝子的にサポートされた治療標的を特定しました. ERP29,MCL1,TNXB,MAPK3,TNFなどの重要な遺伝子は,新しいCAD治療の見込みを示しています.

科学分野:

遺伝学遺伝学とは
薬理学薬理学とは
心血管医学心血管医学

背景:

冠動脈疾患 (CAD) は,治療の選択肢が限られている主要な世界的な死因です.
遺伝的に検証された治療目標の特定は,効果的なCAD治療法の開発に不可欠です.

研究の目的:

メンデルのランダム化 (MR) を用いてCADの遺伝的にサポートされた治療ターゲットを特定し,優先順位付けする.
これらの目標の潜在的なメカニズムと目標への影響を調査する.

主な方法:

2つのサンプルのMRフレームワークでは,血液のシス表現定量特征ロシ (cis-eQTLs) がCADに及ぼす因果関係を分析した.
ステイガーフィルタリング,ベイジアンコロカライゼーション,および感度分析により,MRの発見が統合されました.
媒介と現象全体のMR分析は,メカニズムと遺伝子効果を調査した.

主要な成果:

ヨーロッパの集団におけるCADに関連した66の因果的な薬物投与可能な遺伝子を特定しました.
ERP29,MCL1,TNXB,DAGLB,FES,およびTRPM4はCADとコロカライズされ,東アジアのコホートで複製されました.
MAPK3とTNFは優先対象として強調され,メディエーション分析はBMI,トリグリセリド,血圧,心房細動との関連性を明らかにした.

結論:

この研究では,既知のCAD薬標的を検証し,血圧と脂質代謝に関与する新しい遺伝子 (ERP29,MCL1,TNXB,DAGLB,FES,TRPM4) を発見しました.
MAPK3とTNFは,薬物投与可能な標的として有望であり,関連する心代謝疾患に潜在的に利益をもたらす可能性がある.
これらの特定された標的の臨床的実現可能性と一般化可能性を調査するために,さらなる研究が必要である.

キーワード:

冠動脈動脈病は冠動脈動脈病である.薬剤投与可能なメンデルのランダム化表現定量的な特徴の場所.治療目標の治療を目的としています.

さらに関連する動画

09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K

12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.4K

関連する概念動画

01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

01:11

Genome-wide Association Studies-GWAS

15.8K

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

15.8K

01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

02:46

Genetic Screens

5.8K

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...